C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/04 (2006.01)
Patent
CA 2104267
-72- ABSTRACT OF THE DISCLOSURE: 3-Oxadiazolyl-5,6,7,8-tetrahydro-1,6-naphthyridine derivative of the formula (I): Image (I) wherein Het is an oxadiazole ring, R1 is hydrogen atom, an acyl group, a lower alkyl group or a group of the formula: -CH2R1'(in which R1' is a cyclo-lower alkyl group, a lower alkenyl group, a lower alkynyl group, benzyl group, aryl group or a heteroaromatic group), R2 is a lower alkyl group, a cyclo-lower alkyl group, a lower alkenyl group, a lower alkynyl group, aryl group, a heteroaromatic group, a halogeno-lower alkyl group, a lower alkoxy-lower alkyl group, a lower alkoxy group, a lower alkenyloxy group, a phenoxy group or a lower alkylthio group, or a pharmaceutically acceptable acid addition salt thereof, which are useful as benzodiazepine receptor agonist.
Furukawa Kiyoshi
Odai Osamu
Ohno Kazunori
Oka Makoto
Tominaga Yukio
Dainippon Pharmaceutical Co. Ltd.
Kirby Eades Gale Baker
LandOfFree
3-oxadiazolyl-1,6-naphthyridine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-oxadiazolyl-1,6-naphthyridine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-oxadiazolyl-1,6-naphthyridine derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1613551